Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium sulfate is an inorganic salt that functions primarily as an osmotic laxative. It is widely utilized in bowel-cleansing regimens prior to colonoscopy, often formulated in combination with other sulfate salts (potassium and magnesium) or polyethylene glycol (PEG). The compound works by creating an osmotic gradient that draws water into the intestinal tract, increasing liquid stool volume and promoting bowel evacuation. Additionally, sodium sulfate (often referred to as mirabilite or Glauber's salt in traditional medicine) is used topically to reduce edema and inflammation associated with fractures or pancreatitis. Research also suggests it may lower fecal pH, a potential risk factor for colorectal cancer, and influence hepatic insulin signaling and cholesterol metabolism through the modulation of FGF15 and AKT pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium sulfate.